Fusion Antibodies plc (AIM:FAB)
London
· Delayed Price · Currency is GBP · Price in GBX 6.40
-0.25 (-3.76%)
Jun 17, 2025, 1:29 PM GMT+1
Fusion Antibodies Market Cap
Fusion Antibodies has a market cap or net worth of 7.56 million as of June 17, 2025. Its market cap has increased by 129.72% in one year.
Market Cap
7.56M
Enterprise Value
7.15M
Revenue
1.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.40
Market Cap Chart
Since December 18, 2017, Fusion Antibodies's market cap has decreased from 27.28M to 7.56M, a decrease of -72.30%. That is a compound annual growth rate of -15.73%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 170.36B |
| GSK plc | 61.23B |
| Haleon | 35.62B |
| Smith & Nephew | 9.57B |
| ConvaTec Group | 5.88B |
| Hikma Pharmaceuticals | 4.69B |
| HUTCHMED (China) | 2.15B |
| Genus | 1.30B |